Ameritas Investment Partners, Inc. Global Blood Therapeutics, Inc. Transaction History

Ameritas Investment Partners, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$32.4 - $68.18 $12,020 - $25,294	371 Added 7.91%	5,064 $344,000
Q2 2021 Aug 06, 2021	BUY	$32.46 - $43.42 $152,334 - $203,770	4,693 New	4,693 $164,000
Q2 2020 Aug 05, 2020	SELL	$48.73 - $81.82 $252,323 - $423,663	-5,178 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$41.72 - $87.2 $4,839 - $10,115	116 Added 2.29%	5,178 $265,000
Q4 2019 Feb 13, 2020	BUY	$45.7 - $81.86 $11,196 - $20,055	245 Added 5.09%	5,062 $402,000
Q3 2019 Nov 14, 2019	BUY	$45.35 - $57.91 $8,661 - $11,060	191 Added 4.13%	4,817 $234,000
Q2 2019 Aug 14, 2019	BUY	$52.6 - $63.29 $11,098 - $13,354	211 Added 4.78%	4,626 $243,000
Q1 2019 May 15, 2019	BUY	$39.99 - $53.48 $14,556 - $19,466	364 Added 8.99%	4,415 $234,000
Q2 2018 Aug 13, 2018	BUY	$38.7 - $50.15 $31,347 - $40,621	810 Added 24.99%	4,051 $183,000
Q2 2017 Aug 15, 2017	BUY	N/A	3,241	3,241 $89,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.